These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15567416)

  • 1. Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.
    Hallgren J; Lindahl S; Pejler G
    J Mol Biol; 2005 Jan; 345(1):129-39. PubMed ID: 15567416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of active monomers from tetrameric human beta-tryptase.
    Fajardo I; Pejler G
    Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors.
    Fukuoka Y; Schwartz LB
    Biochemistry; 2004 Aug; 43(33):10757-64. PubMed ID: 15311937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
    Addington AK; Johnson DA
    Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin.
    Hallgren J; Spillmann D; Pejler G
    J Biol Chem; 2001 Nov; 276(46):42774-81. PubMed ID: 11533057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human mast cell beta-tryptase: conversion of inactive monomer to active tetramer at acid pH.
    Ren S; Sakai K; Schwartz LB
    J Immunol; 1998 May; 160(9):4561-9. PubMed ID: 9574563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for activation of mouse mast cell tryptase: dependence on heparin and acidic pH for formation of active tetramers of mouse mast cell protease 6.
    Hallgren J; Karlson U; Poorafshar M; Hellman L; Pejler G
    Biochemistry; 2000 Oct; 39(42):13068-77. PubMed ID: 11041873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidines are critical for heparin-dependent activation of mast cell tryptase.
    Hallgren J; Bäckström S; Estrada S; Thuveson M; Pejler G
    J Immunol; 2004 Aug; 173(3):1868-75. PubMed ID: 15265919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pH.
    Fukuoka Y; Schwartz LB
    J Immunol; 2006 Mar; 176(5):3165-72. PubMed ID: 16493076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of human tryptase-beta with small molecule inhibitors provides new insights into the unusual functional instability and quaternary structure of the protease.
    Selwood T; Smolensky H; McCaslin DR; Schechter NM
    Biochemistry; 2005 Mar; 44(9):3580-90. PubMed ID: 15736967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structures of free and leupeptin-complexed human alphaI-tryptase mutants: indication for an alpha-->beta-tryptase transition.
    Rohr KB; Selwood T; Marquardt U; Huber R; Schechter NM; Bode W; Than ME
    J Mol Biol; 2006 Mar; 357(1):195-209. PubMed ID: 16414069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity.
    Stevens RL; Adachi R
    Immunol Rev; 2007 Jun; 217():155-67. PubMed ID: 17498058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human mast cell tryptase beta: stable expression in Pichia pastoris and purification of fully active enzyme.
    Niles AL; Maffitt M; Haak-Frendscho M; Wheeless CJ; Johnson DA
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():125-31. PubMed ID: 9756742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of recombinant mast cell tryptase.
    Chan H; Elrod KC; Numerof RP; Sideris S; Clark JM
    Protein Expr Purif; 1999 Apr; 15(3):251-7. PubMed ID: 10092484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of three distinct catalytic forms of human tryptase-beta: their interrelationships and relevance.
    Schechter NM; Choi EJ; Selwood T; McCaslin DR
    Biochemistry; 2007 Aug; 46(33):9615-29. PubMed ID: 17655281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I.
    Sakai K; Ren S; Schwartz LB
    J Clin Invest; 1996 Feb; 97(4):988-95. PubMed ID: 8613553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of recombinant gamma-tryptase.
    Yuan J; Beltman J; Gjerstad E; Nguyen MT; Sampang J; Chan H; Janc JW; Clark JM
    Protein Expr Purif; 2006 Sep; 49(1):47-54. PubMed ID: 16815034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase.
    Schwartz LB; Bradford TR; Lee DC; Chlebowski JF
    J Immunol; 1990 Mar; 144(6):2304-11. PubMed ID: 2179409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of mast cell tryptase. An inflammatory mediator.
    Hallgren J; Pejler G
    FEBS J; 2006 May; 273(9):1871-95. PubMed ID: 16640553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin antagonists are potent inhibitors of mast cell tryptase.
    Hallgren J; Estrada S; Karlson U; Alving K; Pejler G
    Biochemistry; 2001 Jun; 40(24):7342-9. PubMed ID: 11401583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.